Bicara Therapeutics Inc Common Stock

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-19
-19
EBITDA
-41,122
-36,234
-31,999
-41,769
EBIT
-41,133
-36,290
-32,018
-41,788
Net Income
-37,386
-36,330
-27,388
-36,846
Net Change In Cash
0
0
0
0
Free Cash Flow
-24,124
-29,290
-25,594
-28,106
Cash
96,685
171,673
436,606
462,065
Basic Shares
55,142
54,563
54,539
54,456

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-56
-19
-10
EBITDA
-155,604
-82,333
-39,870
-37,722
EBIT
-155,709
-82,389
-39,889
-37,732
Net Income
-137,950
-67,995
-51,985
-37,845
Net Change In Cash
0
0
0
0
Free Cash Flow
-107,114
-74,822
-46,214
-32,268
Cash
96,685
489,711
230,440
4,158
Basic Shares
54,676
54,424
51,760
51,760

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.68
2025-09-30
-$0.67
2025-06-30
-$0.50